文献速递中医内科中药与中成药合理使用

抗炎中药预防心肌梗死后心力衰竭的潜力

Potential traditional Chinese medicines with anti-inflammation in the prevention of heart failure following myocardial infarction.
PubMed 文献 · Chin Med · 2023-03-17

炎症在心肌梗死后心力衰竭的发生中起重要作用,抑制梗死后炎症级联是延缓或阻断心衰进展的新策略。目前尚无获批的抗炎药用于预防心梗后心衰。本文综述了部分中药(单味药如黄芪、丹参,复方如瓜蒌薤白汤、四逆汤)在患者或实验模型中改善心功能并抑制炎症的进展,为其潜在应用提供证据。

要点

  • 抗炎中药可能通过抑制TLR4/NF-κB信号及IL-1β、IL-6、TNF-α等炎症因子发挥作用。
  • 单味药(黄芪、丹参)与复方(瓜蒌薤白汤、四逆汤)均显示改善心功能与抗炎潜力。
  • 目前尚无获批的抗炎药用于预防心梗后心衰,中药值得进一步实验与临床评估。

核心结论

  • 部分中药可改善心功能并抑制炎症,有望用于预防或延缓心肌梗死后心力衰竭,但需进一步实验与临床评估。

研究设计与样本

  • 综述类文章,汇总近期关于中药在心肌梗死或心力衰竭患者及实验模型中改善心功能与抑制炎症的研究进展。

主要发现

  • 单味中药(如黄芪、丹参)与中药复方(如瓜蒌薤白汤、四逆汤)在患者或实验模型中均显示改善心功能并抑制炎症。
  • 抗炎作用的主要靶点涉及TLR4/NF-κB信号通路以及促炎细胞因子IL-1β、IL-6或TNF-α。

关键数值与推荐

  • 原文未报告具体数值、比例、阈值、剂量、样本量或P值。

临床怎么用

  • 对于心肌梗死后的患者,可考虑在辨证论治基础上选用具有抗炎证据的中药(如黄芪、丹参或相关复方),但需进一步临床评估。

局限性

  • 原文未明确报告综述的检索范围、纳入研究数量及方法学质量评价。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Inflammation plays an important role in the development of heart failure (HF) after myocardial infarction (MI). Suppression of post-infarction inflammatory cascade has become a new strategy to delay or block the progression of HF. At present, there are no approved anti-inflammatory drugs used to prevent HF following MI. Traditional Chinese medicine (TCM) has been used clinically for cardiovascular disease for a long time. Here, we summarized the recent progress about some TCM which could both improve cardiac function and inhibit inflammation in patients or experimental models with MI or HF, in order to provide evidence for their potential application in reducing the onset of HF following MI. Among them, single Chinese medicinal herbs (eg. Astragalus and Salvia miltiorrhiza) and Chinese herbal formulas (eg. Gualou Xiebai Decoction and Sini Tang) are discussed separately. The main targets for their anti-inflammation effect are mainly involved the TLR4/NF-κB signaling, as well as pro-inflammatory cytokines IL-1β, IL-6 or TNF-α. It is worthy of further evaluating their potential, experimentally or clinically, in the prevention or delay of HF following MI.

来源:Chin Med,查看原文。版权归原作者所有。

引用

  1. Zhang Z, Chen F, Wan J, et al. Potential traditional Chinese medicines with anti-inflammation in the prevention of heart failure following myocardial infarction. Chin Med. 2023. PMID: 36932409. doi:10.1186/s13020-023-00732-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。